UFP Technologies Inc (UFPT)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.36B
Last updated: Nov 17, 2026 at 11:05 AM ET
UFP Technologies Inc (UFPT) Financials: Revenue, Profit and Cash Flow
UFP Technologies reported revenue of $602.80M for the fiscal year ended Dec 31, 2025, up 19.5% from the year before. That year, net income was $68.31M with a net margin of 11.3%, operating cash flow was $91.91M and free cash flow was $78.98M. The quarter ended Sep 30, 2026 had revenue of $172.43M and net income of $20.62M.
Revenue and Margins
The operating margin was 15.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $146.13M, a compound annual rate of 17.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $602.80M | +19.5% | 28.3% | 15.3% | 11.3% |
| Dec 2024 | $504.42M | +26.1% | 29.1% | 16.0% | 11.7% |
| Dec 2023 | $400.07M | +13.1% | 28.1% | 14.4% | 11.2% |
| Dec 2022 | $353.79M | +71.5% | 25.5% | 15.7% | 11.8% |
| Dec 2021 | $206.32M | +15.0% | 24.8% | 10.3% | 7.7% |
| Dec 2020 | $179.37M | -9.6% | 24.9% | 9.3% | 7.5% |
| Dec 2019 | $198.38M | +4.2% | 27.2% | 12.5% | 10.0% |
| Dec 2018 | $190.46M | +28.8% | 25.4% | 10.3% | 7.5% |
| Dec 2017 | $147.84M | +1.2% | 24.0% | 7.9% | 6.2% |
| Dec 2016 | $146.13M | N/A | 23.7% | 8.4% | 5.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 15.8% from the year before. In the quarter ended Sep 2026, net income rose 25.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $602.80M | $504.42M | $400.07M | $353.79M | $206.32M | $179.37M | $198.38M | $190.46M | $147.84M | $146.13M |
| Cost of revenue | $432.39M | $357.73M | $287.85M | $263.53M | $155.21M | $134.69M | $144.42M | $142.15M | $112.36M | $111.48M |
| Gross profit | $170.41M | $146.69M | $112.22M | $90.26M | $51.11M | $44.68M | $53.96M | $48.31M | $35.49M | $34.65M |
| Operating income | $92.34M | $80.90M | $57.66M | $55.40M | $21.22M | $16.73M | $24.71M | $19.61M | $11.69M | $12.24M |
| Net income | $68.31M | $58.98M | $44.92M | $41.79M | $15.89M | $13.37M | $19.75M | $14.31M | $9.21M | $7.97M |
| EBITDA | $111.47M | $95.80M | $68.95M | $83.02M | $29.65M | $24.63M | $32.49M | $27.51M | $17.33M | $17.87M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $172.43M | $173.96M | $154.20M | $148.91M | $154.56M | $151.18M | $148.15M | $144.07M | $145.16M | $110.18M | $105.01M | $101.50M |
| Gross profit | $50.76M | $50.92M | $44.36M | $41.97M | $42.75M | $43.54M | $42.15M | $42.06M | $41.52M | $33.03M | $30.08M | $26.13M |
| Operating income | $27.61M | $28.10M | $23.37M | $21.50M | $23.38M | $24.33M | $23.13M | $22.26M | $24.76M | $17.95M | $15.92M | $12.74M |
| Net income | $20.62M | $20.85M | $17.50M | $17.57M | $16.38M | $17.18M | $17.18M | $16.38M | $16.36M | $13.55M | $12.69M | $11.61M |
Balance Sheet
As of Dec 2025, total debt of $135.46M exceeded cash and equivalents by $115.15M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $655.08M | $629.00M | $404.14M | $378.19M | $334.13M | $203.20M | $188.76M | $189.60M | $138.21M | $127.93M |
| Current assets | $201.00M | $194.94M | $144.63M | $116.35M | $87.32M | $71.86M | $53.25M | $55.63M | $75.07M | $69.85M |
| Cash and equivalents | $20.30M | $13.45M | $5.26M | $4.45M | $11.12M | $24.23M | $3.74M | $3.24M | $37.98M | $31.36M |
| Total liabilities | $231.20M | $286.24M | $118.05M | $140.65M | $139.69M | $26.31M | $26.77M | $49.14M | $14.49M | $14.88M |
| Short-term debt | $12.50M | $12.50M | $4.00M | $4.00M | $4.00M | $0 | $1.15M | $2.86M | $0 | $856.00K |
| Long-term debt | $122.95M | $176.88M | $28.00M | $51.00M | $71.00M | $0 | $325.00K | $22.29M | $0 | $0 |
| Shareholder equity | $423.88M | $342.76M | $286.09M | $237.54M | $194.45M | $176.89M | $161.99M | $140.46M | $123.71M | $113.05M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $682.63M | $681.91M | $674.68M | $665.74M | $652.82M | $634.66M | $642.64M | $629.00M | $638.51M | $422.40M | $407.68M | $404.14M |
| Total liabilities | $196.92M | $219.48M | $235.81M | $241.86M | $248.91M | $249.17M | $281.97M | $286.24M | $309.36M | $112.22M | $112.66M | $118.05M |
| Cash and equivalents | $20.63M | $9.04M | $19.98M | $20.30M | $18.23M | $14.89M | $14.03M | $13.45M | $16.36M | $16.73M | $11.37M | $5.26M |
| Shareholder equity | $485.71M | $462.43M | $438.88M | $423.88M | $403.91M | $385.49M | $360.67M | $342.76M | $329.15M | $310.18M | $295.02M | $286.09M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 85.9% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $91.91M | $66.59M | $41.33M | $17.74M | $14.29M | $25.04M | $31.23M | $21.32M | $17.47M | $9.31M |
| Capital expenditures | $12.93M | $12.87M | $10.49M | $13.78M | $5.39M | $4.37M | $5.78M | $5.43M | $10.38M | $7.21M |
| Free cash flow | $78.98M | $53.72M | $30.84M | $3.96M | $8.90M | $20.67M | $25.45M | $15.89M | $7.09M | $2.10M |
| Dividends paid | N/A | N/A | N/A | $1.68M | $1.68M | $1.02M | $319.00K | N/A | $0 | $0 |
| Investing cash flow | -$27.60M | -$210.16M | -$10.49M | $1.29M | -$101.46M | -$4.26M | -$5.77M | -$82.33M | -$10.38M | -$7.19M |
| Financing cash flow | -$58.16M | $152.39M | -$30.02M | -$25.89M | $74.05M | -$285.00K | -$24.95M | $26.27M | -$475.00K | -$559.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $38.54M | $15.61M | $3.20M | $16.84M | $35.92M | $25.33M | $13.81M | $24.42M | $19.80M | $11.71M | $10.65M | $12.70M |
| Capital expenditures | $3.90M | $1.16M | $1.75M | $3.87M | $3.38M | $2.86M | $2.82M | $3.01M | $5.36M | $2.77M | $1.73M | $2.76M |
| Free cash flow | $34.64M | $14.45M | $1.46M | $12.96M | $32.55M | $22.47M | $10.99M | $21.42M | $14.44M | $8.94M | $8.92M | $9.95M |
Frequently Asked Questions About UFPT
What is UFP Technologies' annual revenue?
UFP Technologies reported revenue of $602.80M for the fiscal year ended Dec 31, 2025.
How fast is UFP Technologies' revenue growing?
Revenue was up 19.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 19.4%.
Is UFP Technologies profitable?
Yes. UFP Technologies reported net income of $68.31M for the fiscal year ended Dec 31, 2025, with a net margin of 11.3%.
How much free cash flow does UFPT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $91.91M minus capital expenditures of $12.93M produced free cash flow of $78.98M.
How much debt does UFP Technologies have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $122.95M, short-term debt of $12.50M and cash and equivalents of $20.30M.
UFPT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts